These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 3859214)

  • 61. Pharmacokinetics of imipenem and cilastatin after their simultaneous administration to the elderly.
    Toon S; Hopkins KJ; Garstang FM; Aarons L; Rowland M
    Br J Clin Pharmacol; 1987 Feb; 23(2):143-9. PubMed ID: 3470047
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Fundamental and clinical studies of imipenem/cilastatin sodium in the field of obstetrics and gynecology].
    Okamura K; Nakakuki M; Yamada K; Ikeno N; Watanabe M; Takahashi K; Muraguchi K; Saito A; Wakisaka T; Murai H
    Jpn J Antibiot; 1986 Jun; 39(6):1526-30. PubMed ID: 3463794
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Role for newer beta-lactam antibiotics in treatment of osteomyelitis.
    Gentry LO
    Am J Med; 1985 Jun; 78(6A):134-9. PubMed ID: 3859212
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Treatment of moderate or severe infections using imipenem/cilastatin. 41 cases based on a multicenter protocol].
    Stahl JP; Chavanet P; Robert D; Croize J; Mercatello A; Bru JP; Aguilaniu F; Portier H; Micoud M
    Pathol Biol (Paris); 1986 May; 34(5):465-9. PubMed ID: 3534723
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Imipenem: first of a new class of beta-lactam antibiotics.
    Barza M
    Ann Intern Med; 1985 Oct; 103(4):552-60. PubMed ID: 3898954
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Imipenem/cilastatin therapy for serious infections in neonates and infants.
    Nalin DR; Jacobsen CA
    Scand J Infect Dis Suppl; 1987; 52():46-55. PubMed ID: 3331042
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Bacterial and clinical studies on imipenem/cilastatin sodium in urological infection].
    Goto T; Kawahara M; Sakamoto N; Ohi Y; Nagata S; Yanase I; Hanabusa A; Imamura A; Shimada T; Kawabata T
    Jpn J Antibiot; 1986 Apr; 39(4):996-1006. PubMed ID: 3463772
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Fundamental and clinical studies on imipenem/cilastatin sodium in the field of obstetrics and gynecology].
    Iwase H; Seto H; Hogaki M; Arai K
    Jpn J Antibiot; 1986 May; 39(5):1350-8. PubMed ID: 3463781
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Effect of imipenem/cilastatin sodium in thirty cases of bone and joint infection].
    Sakurai M
    Jpn J Antibiot; 1986 Jul; 39(7):1947-59. PubMed ID: 3464787
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Fundamental and clinical studies of imipenem/cilastatin sodium in the field of obstetrics and gynecology].
    Fujimoto H; Ikeda K; Yamamoto K; Taguchi S; Shirakawa K
    Jpn J Antibiot; 1986 Jun; 39(6):1607-11. PubMed ID: 3463801
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Review of adverse experiences and tolerability in the first 2,516 patients treated with imipenem/cilastatin.
    Calandra GB; Brown KR; Grad LC; Ahonkhai VI; Wang C; Aziz MA
    Am J Med; 1985 Jun; 78(6A):73-8. PubMed ID: 3859218
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Fundamental and clinical studies of imipenem and imipenem/cilastatin sodium in the field of obstetrics and gynecology].
    Hirabayashi K; Okada E
    Jpn J Antibiot; 1986 May; 39(5):1413-25. PubMed ID: 3463787
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Nephroprotective effect of imipenem/cilastatin in reducing cyclosporine toxicity.
    Sido B; Hammer C; Mraz W; Krombach F
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1755-8. PubMed ID: 3469804
    [No Abstract]   [Full Text] [Related]  

  • 74. In vitro and in vivo studies of imipenem-cilastatin alone and in combination with gentamicin against Listeria monocytogenes.
    Kim KS
    Antimicrob Agents Chemother; 1986 Feb; 29(2):289-93. PubMed ID: 3087277
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Pyonephrosis presenting as toxic shock syndrome in infancy.
    Alpert G; Campos JM; Snyder HM
    Pediatr Infect Dis; 1985; 4(5):561-2. PubMed ID: 4047968
    [No Abstract]   [Full Text] [Related]  

  • 76. Cilastatin does not alter superoxide dismutase activity.
    Proctor RA; Textor JA
    Antimicrob Agents Chemother; 1985 Nov; 28(5):691-2. PubMed ID: 3867330
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Stimulation of granulocyte functions in vitro by imipenem and the renal enzyme inhibitor MK 0791.
    Gnarpe H; Belsheim J; Blomqvist C; Lundbäck A
    Antimicrob Agents Chemother; 1984 Feb; 25(2):179-81. PubMed ID: 6585179
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Disposition of radiolabeled imipenem and cilastatin in normal human volunteers.
    Norrby SR; Rogers JD; Ferber F; Jones KH; Zacchei AG; Weidner LL; Demetriades JL; Gravallese DA; Hsieh JY
    Antimicrob Agents Chemother; 1984 Nov; 26(5):707-14. PubMed ID: 6595962
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Studies on the degradation of imipenem within serum and a renal kidney fraction.
    Köller M; Brom J; Schönfeld W; Knöller J; König W
    Zentralbl Bakteriol Mikrobiol Hyg A; 1986 May; 261(3):330-7. PubMed ID: 3090805
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Compressed pellet X-ray diffraction monitoring for optimization of crystallinity in lyophilized solids: imipenem: cilastatin sodium case.
    Ryan JA
    J Pharm Sci; 1986 Aug; 75(8):805-7. PubMed ID: 3464737
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.